Biosynth
↗Staad, Switzerland
Biosynth is a global contract development and manufacturing organization (CDMO) and supplier of critical raw materials for the life sciences, pharmaceutical, and diagnostic industries. The company operates at the intersection of chemistry and biology, providing a vast catalog of over half a million research products alongside custom synthesis and manufacturing services.
Biosynth's capabilities span complex chemistry, peptides, and key biologics, including enzymes and antibodies. The company supports projects from early-stage discovery and route scouting through to GMP manufacturing and commercial supply, with facilities located across Europe, Asia, and North America.
CLASSIFICATION
SIZE & FINANCIALS
Employees:501-1000
Founded:1966
Ownership:subsidiary
Status:acquired
FUNDING
Investors:KKR, Ampersand Capital Partners, Arax Capital Partners
PIPELINE
Stage:Discovery
Lead Drug Stage:N/A (Service Provider)
Modalities:Small molecule, Peptides, Bioconjugates, Oligonucleotides
Active Trials:0
Trial Phases:-
FDA Approvals:0
EMA Approvals:0
CORPORATE STRUCTURE
Parent Company:KKR
Acquired By:KKR (2021-11-01)
Subsidiaries:VIO Chemicals, Pepceuticals, Celares, Aalto Bio Reagents, EUCODIS Bioscience
Key Partnerships:Various pharmaceutical and biotech companies (CDMO service agreements)
COMPETITION
Position:Niche Player
Competitors:MilliporeSigma, CABB, Synthego, Sutro Biopharma, Avidity Biosciences
LEADERSHIP
Key Executives:
Matt Gunnison - CEO
Kieran Murphy - Chairman
Marie Leblanc - EVP of Life Sciences
Scientific Founders:Hans Spitz
LINKS
⚠
Is this information incorrect? This profile was AI-generated from publicly available sources and may contain errors. If you are a representative of Biosynth and believe any information on this page is inaccurate, we will promptly correct or remove it.REPORT AN ERROR
Disclaimer: IntuitionLabs.ai is not affiliated with, endorsed by, or associated with Biosynth. The information on this page was compiled using AI from publicly available sources and may be incomplete, outdated, or contain errors. We are committed to correcting inaccuracies promptly upon notice. For official information, please visit the company's website directly.